Skip to main content



  • Chemistry
  • Health Assessment and Safety

General Information

Name Information
Matrix:Serum / Plasma
Application:Insurance Risk Assessment, Wellness
Turnaround Time:Daily
Analytical - Method:The enzyme aspartate aminotransferase (AST) is widely distributed in tissue, principally hepatic, cardiac, muscle, and kidney. Elevated serum levels are found in diseases involving these tissues. Hepatobiliary diseases, such as cirrhosis, metastatic carcinoma, and viral hepatitis also increase serum AST levels. Following myocardial infarction, serum AST is elevated and reaches a peak two days after onset. In patients undergoing renal dialysis or those with vitamin B6 deficiency, serum AST may be decreased. The apparent reduction in AST may be related to decreased pyridoxal phosphate, the prosthetic group for AST, resulting in an increase in the ratio of apoenzyme to holoenzyme. Two isoenzymes of AST have been detected, cytoplasmic and mitochondrial. Only the cytoplasmic isoenzyme occurs in normal serum, while the mitochondrial, together with the cytoplasmic isoenzyme, has been detected in the serum of patients with coronary and hepatobiliary disease.
Reportable - Test Results Type:Quantitative
Units - Conventional:U/L

Specimen Information

Name Information
Minimum Volume:300 µL
Preferred Volume:500 µL
Rejection Criteria:

Improper labeling, improper sample handling, and wrong sample type.

Collection Instructions:

See “Blood Collection”

Collection Patient Preparation:NA
Container:For specimen collection and preparation, only use suitable tubes or collection containers. Only the specimens listed below were tested and found acceptable. Serum (free from hemolysis). Plasma (free from hemolysis): Li-heparin and K2-EDTA plasma.